Panel Discussion: What is the Best Modality & Delivery Approach to PRR-Pathway Targeting?

Time: 1:30 pm
day: Day Two


  • Discussing safety profiles, dosing and scheduling considerations, therapeutic window
  • Dissecting drug design approach for systemic and intratumoral
  • Understanding possible regulatory considerations
  • Mechanisms of action that are leading to strong efficacy
  • Enhancing administration and delivery of therapies for safe and effective clinical outcomes
  • Systemic delivery technologies vs intra-tumoral delivery technologies